The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Advanced Accelerator Applications; Merck Serono; Pierre Fabre; Sandoz; Sanofi; SERVIER
Research Funding - Amgen
Travel, Accommodations, Expenses - Pierre Fabre; SERVIER
One-year duration of nivolumab plus ipilimumab in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up of the GERCOR NIPICOL phase II study.
 
Romain Cohen
Honoraria - MSD Oncology; Pierre Fabre
Consulting or Advisory Role - Exeliom Biosciences
Research Funding - SERVIER
Travel, Accommodations, Expenses - Amgen
 
Aurelia Meurisse
No Relationships to Disclose
 
Thomas Pudlarz
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; MSD; Roche; SERVIER
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Ipsen
Research Funding - Pierre Fabre (Inst); Roche; Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; Roche; Roche; SERVIER
Other Relationship - Incyte; MSD Oncology
 
David Tougeron
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Sanofi
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Thibault Mazard
No Relationships to Disclose
 
Benoist Chibaudel
Consulting or Advisory Role - Bayer; Pfizer; Roche; Sanofi; Servier
Travel, Accommodations, Expenses - Amgen; Merck; MSD; Roche; Sanofi
 
Marie-Line Garcia-Larnicol
No Relationships to Disclose
 
Magali Svrcek
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ventana Medical Systems
 
Yves Menu
Honoraria - BMS
 
Dewi Vernerey
Consulting or Advisory Role - AC Biotech SA; Fondazione Smith Kline; Gercor; HalioDx; Incyte
 
Thierry Andre
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Pierre Fabre; Roche/Genentech; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Pierre Fabre; Seagen; SERVIER; Tesaro; Transgene
Travel, Accommodations, Expenses - MSD Oncology